Cibc World Market Inc. Bio N Tech Se Transaction History

Cibc World Market Inc.

$47.5 Billion
Q2 2025

A detailed history of Cibc World Market Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Cibc World Market Inc. holds 3,048 shares of BNTX stock, worth $316,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,048

Previous 3,049 0.03%

Holding current value

$316,717

Previous $277,000 16.97%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$86.65 - $120.54 $86 - $120	-1 Reduced 0.03%	3,048 $324,000
Q1 2025 May 14, 2025	SELL	$91.06 - $126.88 $10,016 - $13,956	-110 Reduced 3.48%	3,049 $277,000
Q4 2024 Jan 23, 2025	BUY	$99.72 - $122.68 $315,015 - $387,546	3,159 New	3,159 $360,000
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $29,133 - $45,768	246 Added 15.77%	1,806 $271,000
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $176,922 - $253,790	-1,386 Reduced 47.05%	1,560 $210,000
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $4,560 - $6,890	-37 Reduced 1.24%	2,946 $439,000
Q1 2022 May 12, 2022	BUY	$126.25 - $231.85 $22,725 - $41,733	180 Added 6.42%	2,983 $509,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $423,531 - $708,726	1,955 Added 230.54%	2,803 $723,000
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $174,628 - $379,251	848 New	848 $231,000
Q1 2021 May 11, 2021	SELL	$85.73 - $119.5 $214,067 - $298,391	-2,497 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$72.71 - $129.54 $181,556 - $323,461	2,497 New	2,497 $204,000

Others Institutions Holding BNTX

# of Institutions

320

Shares Held

40.7M

Call Options Held

1.39M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Bio N Tech Se Transaction History